{"date":"2025-01-07","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6550-2025-01-07-1608-17rcma5","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-01-07","time":"16:08:29","subject":"更正本公司民國113年01-11月之資金貸與資訊揭露明細表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-01-07 16:08，「更正本公司民國113年01-11月之資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-01-07-1457-3xgyxz","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-01-07","time":"14:57:52","subject":"董事會通過本公司重要營運主管、研發主管、代理發言人及稽核主管異動公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-01-07 14:57，「董事會通過本公司重要營運主管、研發主管、代理發言人及稽核主管異動公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}